Anastrozole - Solicitation

The Defense Logistics Agency (DLA) Solicitation SPE2D2‑25‑R‑0007 seeks commercial‑item pharmaceutical products and related services under a firm‑fixed‑price requirements contract with options. Offerors must submit a complete electronic proposal via the DIBBS system, including a non‑price volume (technical approach, past performance, evaluation data) and a price volume. Required data elements include the offeror’s UEI, CAGE code, remittance address, item numbers, quantities, and, for each product, the name and street address of the actual manufacturing facility (foreign headquarters, distributors, or agents are not acceptable). Offerors must also provide quarterly sales reports, a cost‑recovery fee, and, if applicable, FDA warning‑letter status with corrective‑action documentation. Samples, when required, are to be provided at no cost to the Government and returned unless destroyed during testing. The solicitation incorporates numerous FAR and DFARS clauses (e.g., 52.203‑3 Gratuities, 52.204‑7 SAM registration, 52.229‑11/‑12 foreign procurement taxes, 252.203‑7000/‑7003/‑7005 former DoD official compensation) and mandates compliance with commercial‑entity code reporting, ownership disclosures, and alternative line‑item proposals. Offerors may submit multiple or alternative offers, each evaluated separately, and must adhere to the DIBBS upload instructions (see the DIBBS Help document and contact Nancy Fernandez for technical issues). Late submissions, modifications, or withdrawals are the offeror’s responsibility.

Notice ID

73182df3e4f24289b351da883319d2bd

Solicitation Number

SPE2D2-25-R-0007

NAICS Code

325412

Classification Code

6505